Bicalutamide (Casodex) 150 mg as immediate therapy in patients with localized or locally advanced prostate cancer significantly reduces the risk of disease progression
M. Wirth*, C. Tyrrell, M. Wallace, K. P. Delaere, M. Sánchez-Chapado, J. Ramon, J. Hetherington, F. Pina, C. F. Heynes, T. M. Borchers, T. Morris, A. Stone
Research output: Contribution to journal › Article › peer-review
79Scopus
citations
Fingerprint
Dive into the research topics of 'Bicalutamide (Casodex) 150 mg as immediate therapy in patients with localized or locally advanced prostate cancer significantly reduces the risk of disease progression'. Together they form a unique fingerprint.